A randomized, open label study comparing the effect of first-line therapy with Tarceva [erlotinib] + gemcitabine versus gemcitabine monotherapy on treatment response in treatment-naive patients with advanced non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 17 May 2016
At a glance
- Drugs Erlotinib (Primary) ; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms FiGhT
- Sponsors Roche
- 01 Sep 2012 Results published in Oncology Reports.
- 18 Sep 2009 Actual end date (Jul 2009) and actual number of patients (17) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History